Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong.

The official countdown is underway. With just two weeks until BIOHK2026 convenes at the Hong Kong Convention and Exhibition Centre (HKCEC) from September 9-12, 2026, BIOHK2026—organized by the Hong Kong Biotechnology Organization (HKBIO)—serves as a world-class international landmark event bridging biotech innovation, industrial capacity, venture capital, and regulatory bodies. Leveraging Hong Kong's strategic position as Asia's premier "Super-Connector" and biotech financing gateway, this 5th annual convention will welcome over 10,000 professional attendees, 400+ world-class speakers, and delegations spanning over 40 countries and regions.

To assist international delegates in maximizing their strategic footprint, HKBIO has published a comprehensive operational guide detailing the core pillars of this year's convention.

1. Featured Exhibition Pavilions: Landmark Regional & International Innovation Clusters

Spanning expansive exhibition halls hosting nearly 200 global exhibitors, BIOHK2026 brings together prominent regional biotech hubs, state-backed industrial platforms.

Greater Bay Area & Mainland Innovation Hubs: Major regional delegations including Guangzhou and Shenzhen will showcase their dense biotech clusters, pioneering biotech enterprises, clinical trial capacity, and advanced biomanufacturing strength. A central spotlight will also be cast on the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone, highlighting cross-border policy synergy, joint research initiatives, and frictionless data and sample flows between Hong Kong and Mainland China.

Leading Institutional & Corporate Delegations: Backed by Mainland China and connected to global markets, Hong Kong serves as an ideal pivot for biotech innovation. As a premier institutional partner, CITIC Group has joined hands with HKBIO for BIOHK2026. As a flagship implementation of CITIC's strategy, this landmark partnership leverages abundant industrial resources, expert think tanks, and deep market entry experience to fully elevate the scale and international stature of the convention.

Nordic Future Health Pavilion: Co-organized by the Hong Kong Chamber of Commerce in Sweden (HKCCSE) and supported by the Consulate General of Sweden in Hong Kong and AstraZeneca Hong Kong, this dedicated pavilion brings around 10 leading Nordic life science enterprises and organizations directly to the main convention floor. Key participants will showcase breakthrough technologies spanning precision T-cell receptor-engineered T-cell therapies (Anocca), stromal cell therapies (NextCell Pharma), cancer immunotherapies and vaccines (ExpreS2ion Biotechnologies), digital health (Keeada Health, SoftMed), ophthalmology (Uveo), and biotech development (Veltio Pharma).

2. High-Impact Conference Program: 50+ Multi-Track Industry Forums

Across seven dynamic stages hosting over 400 world-class speakers, the four-day conference features high-level keynotes and more than 50 vertical forums bridging global biotech ecosystems:

Frontier Therapeutics & Advanced Sciences: Dedicated tracks covering AI-driven Drug Discovery & Healthcare, Cell and Gene Therapy (CGT) source innovation, Brain-Computer Interface (BCI), Synthetic Biology, Spatiotemporal Omics in infectious diseases, mRNA/Exosome therapies, Longevity & Anti-Aging science, and Modernization of Traditional Chinese Medicine (TCM) and other cutting-edge disciplines.

Global Regulatory, Clinical & Policy Frameworks: High-level keynotes and dedicated sessions exploring regulatory harmonization, highlighting the newly established Hong Kong Centre for Medical Products Regulation (CMPR), GBA Clinical Trial Collaboration via "One Institute, One Center", and cross-border medical integration. Anchored by these initiatives, BIOHK2026 brings together top regional drug regulators—including representatives from Hong Kong, Singapore, Malaysia, Indonesia and Pakistan—to facilitate international collaboration and empower the global expansion of innovative therapeutics.

Global Cooperation Forum Series: Flagship international sessions exploring cross-border technology transfer, investment, and market access synergies across key global regions—including dedicated tracks for North America & Europe, Latin America, Southeast Asia/ASEAN, Belt and Road Economies, GBA, and specialized regional showcases like Hainan.

Biotech Investment & BD Summits: Capitalizing on Hong Kong's position as the world's second-largest biotech financing center—supported by HKEX Chapter 18A enabling non-revenue biotech listings and a robust capital ecosystem—forums will bring together corporate BD leads, investors, and dealmakers to analyze macro trends, primary vs. secondary market valuation, cross-border licensing, and value creation.

3. Concurrent Highlights: Strategic Matchmaking, Pitching & Executive Networking

Complementing the exhibition and conference tracks, BIOHK2026 features high-impact concurrent activities designed to convert participation into actionable dealmaking:

Integrated One2One Partnering Engine (Included with Delegate Pass): Every registered pass holder gains full access to the digital platform. Delegates can utilize multi-dimensional filters—categorizing counterparts by technology modalities, therapeutic focus, development stages, and specific collaboration goals—to pre-book 30-minute face-to-face sessions in dedicated private partnering suites at HKCEC.

BIOHK2026 Pitching Competition: Serving as a premier global launchpad for healthcare innovation, this competitive roadshow stage features high-potential biotech startups, university spin-offs, and early-stage innovators pitching platform technologies directly to rooms filled with global biotech investors, corporate BD leads, and industry mentors.

Regulatory Roundtables & Heavyweight Leaders: Strategic dialogues and closed-door consultations linking biotech developers with industry visionaries and global opinion leaders. Featuring keynotes and insights from renowned heavyweights across policy, academia, and top-tier venture capital, these sessions provide a premier platform to navigate international market access and global growth strategies.

Victoria Harbour Night Cruise Networking: A signature evening event bringing together industry leaders, investors, and international delegates for an exclusive night cruise along Victoria Harbour, providing an inspiring setting to deepen connections and discuss strategic partnerships against Hong Kong's skyline.

Public Engagement Day: The convention wraps up on Saturday, September 12, with a dedicated Public Engagement Day open to the community, highlighted by two featured tracks: "Junior Scientist: Biotech STEAM Discovery Day" to inspire next-generation scientific curiosity, and "Healthy Futures—Where East Meets West" exploring integrative health, wellness innovation, and science communication.

"BIOHK2026 is engineered as Asia's premier platform connecting source innovation to global commercialization," stated an HKBIO spokesperson. "We invite global biotech leaders, investors, and pioneers to gather in Hong Kong this September to capitalize on new market opportunities and shape the future of global healthcare."

Maximize Your Presence—Pre-Book Your Calendar Today!

September 9-12, 2026 | BIOHK2026—Where Leaders Unite Biotech Advances

We cordially invite global biopharma executives, researchers, investors, regulators, clinical experts, and industry leaders to gather in Hong Kong and explore the new frontiers of biotechnology.

• Registration: https://www.bio-hk.com/
• Exhibition Inquiries: kelvin.chan@hkbio.org.hk
• Media Contact: lily.wong@hkbio.org.hk

For further details, please contact us via the channels above.

About HKBIO

The Hong Kong Biotechnology Organization (HKBIO) is a leading non-profit organization dedicated to advancing the growth, internationalization, and innovation of Hong Kong's life sciences ecosystem. Bringing together leaders from government, industry, academia, research, and capital markets, HKBIO serves as a Super-Connector, fostering cross-border collaboration, accelerating clinical translation, and supporting the commercialization of biotechnology innovation across the Asia-Pacific region. Through its initiatives, HKBIO continues to strengthen Hong Kong's position as a leading international biotechnology and healthcare innovation hub while helping transform scientific breakthroughs into real-world healthcare solutions.

For more information, please visit https://www.bio-hk.com/.

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

Approximately half of the exhibition space is already booked, with participation from more than 30 countries and six confirmed pavilions in the inaugural edition.

• Confirmed exhibitors include industry leaders such as ABB, HYT Engineering, and VIVOTEK.
• "Confirmation of the strong interest in a dedicated transport technology platform for Asia", says Kai Mangelberger of Messe Berlin.
• Strong presence of InnoTrans Asia at InnoTrans in Berlin (22-25 September).

SINGAPORE, Aug. 27, 2026 /PRNewswire/ -- InnoTrans Asia 2027 has reached a significant milestone, with approximately 50 per cent of the available exhibition space booked more than one year before the event opens at Singapore EXPO (September 7-9 2027).

Exhibitors from more than 30 countries have confirmed their participation, reflecting sustained international interest in the new transport technology exhibition for the Asian market.

"The booking milestone and the range of companies already confirmed demonstrate the strong interest in a dedicated transport technology platform for Asia," said Kai Mangelberger, Senior Vice President Mobility, Messe Berlin: "The exhibitor line up brings together different areas of the industry and will support closer exchange between international technology providers and the organisations planning, developing and operating transport systems across the region."

Already six confirmed pavilions for InnoTrans Asia 2027

Confirmed exhibitors include industry leaders such as ABB, HYT Engineering, VIVOTEK, DB Engineering & Consulting, Frequentis, Bozankaya Rail Systems A.Ş., Continental, HARTING Singapore Pte Ltd, and Vossloh AG among others. The exhibitor line up brings together companies across the segments Railway Technology, Railway Infrastructure, Interiors, Tunnel Construction and Public Transport.

InnoTrans Asia will also feature pavilions representing Australia, Germany, France, Japan, Spain and Switzerland. These collective presentations will provide participating companies with a platform to present their expertise and engage with transport authorities, operators and industry partners from across Asia.

"Strategic platform": Industry leaders confirm their participation

The early commitment from established international and regional companies reflects the growing importance of building closer relationships with customers, partners and transport stakeholders across Asian markets.

"Bozankaya's early commitment to InnoTrans Asia 2027 reflects our long-term vision for the Asian market and our ambition to contribute to the region's rapidly evolving mobility landscape", says Aytunç Günay, Chairman of the Bozankaya Board: "We see the event as a strategic platform to showcase our innovative and sustainable transport solutions, strengthen existing relationships, and build new partnerships that will support the future of urban mobility across Asia."

"As rail and transportation networks across Asia expand and modernize, InnoTrans Asia 2027 is a strategic platform for HARTING to showcase cutting-edge connectivity solutions, engage with key decision-makers, and strengthen partnerships — reinforcing our position as a trusted partner for robust electrical and electronic interfaces that drive innovation in sustainable mobility across the region", says Mabel Low, HARTING's Managing Director and Corporate Regional Manager, APAC.

"Singapore is an ideal gateway to the fast-growing ASEAN market", says Stefan Geisperger, COO International Business, DB Engineering & Consulting: "InnoTrans Asia provides a strong platform to connect with clients and partners, strengthen our local presence and showcase DB Engineering & Consulting's expertise in sustainable, future-ready transport solutions across Southeast Asia and beyond."

Meet InnoTrans Asia at InnoTrans Berlin: Several events at trade booth

The InnoTrans Asia team will be present at InnoTrans in Berlin for the first time from September 22 to 25, 2026. At their 72-square-meter booth in CityCube Berlin, Hall B (Booth 305), companies can meet the team to learn more about the concept behind the inaugural InnoTrans Asia 2027 in Singapore, discuss participation opportunities, and receive information on the discounted early-bird rates available until the end of October. The booth will also feature contests and other activities, and meetings with the InnoTrans Asia team can be arranged in advance. For more information, visit www.innotrans-asia.com or contact exhibitor@innotrans-asia.com.

- END-

About InnoTrans Asia

InnoTrans Asia is the international trade fair for transportation technology focused on the Asian market. It covers the key segments of railway technology, railway infrastructure, public transport, interiors, and tunnel construction, and offers a platform for innovation, networking, and business development in the region. InnoTrans Asia is organized by Messe Berlin, which also hosts InnoTrans in Berlin (September 22 – 25, 2026). InnoTrans Asia will take place from September 7 – 9, 2027, at the Singapore Expo grounds in Singapore. For more information, visit https://www.innotrans-asia.com/ and https://www.innotrans.de/en, as well as on LinkedIn.

About Messe Berlin

Berlin has been a trade fair venue for over 200 years, and for many decades one of the most important worldwide. As the trade fair company owned by the capital, every year Messe Berlin conceives, markets and organises hundreds of live events. It aims to be an outstanding host for visitors to every event, to give individuals an optimum boost for their business and ensure fair conditions for everyone. This approach is reflected in the company's slogan 'Messe Berlin – Hosting the World'.

More: Home - Messe Berlin | Follow us: Messe Berlin | LinkedIn

Press contacts:

Messe Berlin GmbH

Emanuel Höger
Press Spokesman and Press and Public Relations Director
Group Corporate Communications
Messe Berlin Group
www.messe-berlin.com

InnoTrans Asia

Simon Pausch
Press Spokesman
T +49 (30) 3038 – 6525
simon.pausch@messe-berlin.de
www.innotrans-asia.com

Management Board:

Dr. Mario Tobias (CEO), Dirk Hoffmann
Chairman of the Supervisory Board: Dr. Eric Schweitzer
Companies register: Amtsgericht (District Court) Charlottenburg, HRB 5484 B

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Global Transport Leaders Confirm Their Presence at InnoTrans Asia 2027